OssDsign (OSSD) Stock Overview
Designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
OSSD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
OssDsign AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 10.54 |
| 52 Week High | SEK 16.72 |
| 52 Week Low | SEK 6.09 |
| Beta | 1.09 |
| 1 Month Change | -22.39% |
| 3 Month Change | -28.20% |
| 1 Year Change | 72.50% |
| 3 Year Change | 166.50% |
| 5 Year Change | -33.08% |
| Change since IPO | -54.17% |
Recent News & Updates
Recent updates
Optimistic Investors Push OssDsign AB (publ) (STO:OSSD) Shares Up 31% But Growth Is Lacking
May 08
Pure Play Orthobiologics Will Expand US Healthcare Access
Strategic shift to orthobiologics boosts growth and operational efficiency, enhancing future revenue and sustaining high net margins.OssDsign AB (publ)'s (STO:OSSD) 25% Price Boost Is Out Of Tune With Revenues
Feb 21Analysts Are Upgrading OssDsign AB (publ) (STO:OSSD) After Its Latest Results
Feb 07OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 15OssDsign AB (publ)'s (STO:OSSD) Share Price Matching Investor Opinion
Nov 13OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 23We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth
Aug 06Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now
Jun 19Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely
Mar 19Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation
Aug 19Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?
Feb 23Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?
Jul 15Shareholder Returns
| OSSD | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -18.9% | -1.5% | -2.0% |
| 1Y | 72.5% | -14.0% | 0.9% |
Return vs Industry: OSSD exceeded the Swedish Medical Equipment industry which returned -14% over the past year.
Return vs Market: OSSD exceeded the Swedish Market which returned 0.9% over the past year.
Price Volatility
| OSSD volatility | |
|---|---|
| OSSD Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: OSSD has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: OSSD's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 33 | Morten Henneveld | www.ossdsign.com |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft for dual bone formation pathways through fusion mass. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (publ) Fundamentals Summary
| OSSD fundamental statistics | |
|---|---|
| Market cap | SEK 1.17b |
| Earnings (TTM) | -SEK 41.76m |
| Revenue (TTM) | SEK 176.48m |
Is OSSD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSSD income statement (TTM) | |
|---|---|
| Revenue | SEK 176.48m |
| Cost of Revenue | SEK 6.36m |
| Gross Profit | SEK 170.12m |
| Other Expenses | SEK 211.88m |
| Earnings | -SEK 41.76m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 10, 2026
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 96.40% |
| Net Profit Margin | -23.66% |
| Debt/Equity Ratio | 0% |
How did OSSD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/09 20:46 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
OssDsign AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Rickard Anderkrans | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |